Docetaxel
Last Updated: 09/19/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22217 publications
Real-World Comparison of Abiraterone Acetate Versus Docetaxel in Combination With Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Cohort Study From Vietnam.
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: August 23, 2026
A Review on Analytical Insights into Impurity Profiling of Selected Anticancer Agents: Tinibs and Taxanes.
Journal: Critical reviews in analytical chemistry
Published: August 23, 2026
APUC-6 Genes as a Potential Prognostic and Predictive Biomarker in the CHAARTED Prostate Cancer Trial.
Journal: JCO precision oncology
Published: August 21, 2026
Pathologic Complete Response (pCR) Rate and Predictors of Response to Taxane, Trastuzumab, and Pertuzumab in HER2‑Positive Breast Cancer: Secondary Analyses of EA1181/CompassHER2 pCR.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 20, 2026
Taxane therapy in mCRPC: current positioning and emerging strategies to overcome resistance.
Journal: Expert opinion on investigational drugs
Published: August 19, 2026
Evaluation of triplet therapy combined with robot-assisted cytoreductive prostatectomy for high-volume metastatic prostate cancer: a multicentre randomised controlled trial protocol.
Journal: BJU international
Published: August 14, 2026
Invasive Breast Cancer Complicated by Colitis After TCbHP Chemotherapy: A Case Report.
Journal: The American journal of case reports
Published: August 09, 2026
Clinical and economic outcomes of cabazitaxel versus Lu-PSMA in mCRPC: a US perspective.
Journal: Journal of medical economics
Published: August 07, 2026
HER2-Positive Breast Cancer Brain Metastasis Recurred after Whole-Brain Radiotherapy and Successfully Treated with Trastuzumab Deruxtecan
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: August 04, 2026
Concurrent Ocular and Dermatologic Toxicities Associated With Docetaxel Chemotherapy.
Journal: Journal of the advanced practitioner in oncology
Published: August 01, 2026
Last Updated: 09/19/2026